News

AlayaCare Named Preferred Home Care Technology Partner by Closing the Gap Healthcare

TORONTO, ON / ACCESSWIRE / April 4, 2024 / Closing the Gap Healthcare (CTG) announced today that it has signed…

2 years ago

Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI

The CEPI-funded study will evaluate the safety, tolerability, and immunogenicity of IAVI's single dose Lassa fever vaccine candidateKey takeaways:Participants in…

2 years ago

IHM Senior Living Community Becomes Licensed by the State of Michigan for Assisted Living Services

Community is now open for all levels of careMONROE, MI / ACCESSWIRE / April 4, 2024 / The IHM Senior…

2 years ago

Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections

BOULDER, CO / ACCESSWIRE / April 4, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing…

2 years ago

CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK

Potentially differentiated, multivalent candidate encodes antigens matched to all four WHO-recommended flu strainsFor influenza A strains, geometric mean titers numerically…

2 years ago

PLHM Expands Presence in Alberta with Acquisition of a Clinic in Fort Saskatchewan and an Additional Virtual Presence Across Canada

Calgary, Alberta--(Newsfile Corp. - April 4, 2024) - PLHM, a leading healthcare solutions provider, is pleased to announce the successful…

2 years ago

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an…

2 years ago

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO): Fiscal Year 2024 Third Quarter Highlights Completed the sale of its PICC and Midline…

2 years ago

AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE

New Indication for Treatment of Pulmonary Embolism Enhances Device Utility in Critical Medical ScenariosLATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a…

2 years ago